JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by CHEN, K. K.
Right arrow Articles by ELDERFIELD, R. C.
Right arrow Search for Related Content
PubMed
Right arrow Articles by CHEN, K. K.
Right arrow Articles by ELDERFIELD, R. C.
Journal of Pharmacology And Experimental Therapeutics, Vol. 76, Issue 1, 81-88, 1942
Copyright © 1942 by American Society for Pharmacology and Experimental Therapeutics


SYNTHETIC DERIVATIVES OF STROPHANTHIDIN

K. K. CHEN 1 and ROBERT C. ELDERFIELD 1

1 From the Lilly Research Laboratories, Indianapolis, and the Department of Chemistry, Columbia University, New York City

1. Strophanthidin acetate and 7 synthetic glycosides of strophanthidin all have a digitalis-like action.

2. When assayed in cats and frogs, strophanthidin acetate, strophanthidin-beta-d-glucoside, -d-xyloside, and -l-arabinoside, prove more potent than strophanthidin. Strophanthidin-beta-tetraacetyl-d-glucoside, -triacetyl-d-xyloside, -triacetyl-l-arabinoside, and -tetraacetyl-d-galactoside, on the other hand, are weaker than strophanthidin.

3. Strophanthidin-beta-d-glucoside and -l-arabinoside are also more potent than cymarin, the natural glycoside from which strophanthidin is originally obtained. Strophanthidin-beta-d-xyloside is at least as active as cymarin.

Submitted on June 5, 1942







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1942 by the American Society for Pharmacology and Experimental Therapeutics.